[HTML] mdpi.com

[HTML][HTML] Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - Cancers, 2023 - mdpi.com
Simple Summary Radioligand therapy with [177Lu] Lu-DOTA-TATE is a therapeutic option
for adult patients with somatostatin-receptor–positive gastroenteropancreatic …
相关文章
[HTML] nih.gov

[HTML][HTML] Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - Cancers, 2023 - ncbi.nlm.nih.gov
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - mayoclinic.elsevierpure.com
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - ohiostate.elsevierpure.com
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - ohsu.elsevierpure.com
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

T Halfdanarson, N Mallak, S Paulson… - Cancers, 2023 - iro.uiowa.edu
Abstract Simple Summary Radioligand therapy with [177Lu] Lu-DOTA-TATE is a therapeutic
option for adult patients with somatostatin-receptor–positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - providence.elsevierpure.com
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy.

TR Halfdanarson, N Mallak, S Paulson… - Cancers, 2023 - europepmc.org
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy.

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - search.ebscohost.com
Abstract Simple Summary: Radioligand therapy with [< sup> 177</sup> Lu] Lu-DOTA-TATE
is a therapeutic option for adult patients with somatostatin-receptor–positive …

Monitoring and Surveillance of Patients with Gastroenteropancreatic Neuroendocrine Tumors Undergoing Radioligand Therapy

TR Halfdanarson, N Mallak, S Paulson… - …, 2023 - search.proquest.com
Abstract Radioligand therapy (RLT) with [177 Lu] Lu-DOTA-TATE is a standard of care for
adult patients with somatostatin-receptor (SSTR)-positive gastroenteropancreatic …